This elevation in hormone levels can stimulate the production of MMP-9 by TAMs, creating a favorable environment for angiogenesis, invasion, and the production of VEGF, IL-6, and MMP-9 in patients with ovarian cancer and lung adenocarcinoma [84,88]. This evidence concerns the gene MMP9 and ovarian cancer.